INTRODUCTION
Healthcare Associated Infections (HAI), formerly known as nosocomial or in-hospital, are those infections that did not manifest nor were incubated at the time of admission and the patient acquired it during treatment for any medical or surgical condition. It is necessary that they occur after 48 hours of hospitalization¹.
HAI are the most frequent complication of hospitalized patients. In Spain, according to the data provided by the EPINE Project², prevalence of HAI is estimated at around 7.5-8% in the last 4 years, with a recovery in 2015 compared to the previous years. This prevalence increases to 23.52% in critically ill patients, with intensive care units being the most prevalent areas.
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The development of infections is associated with multiple causes, including, but not limited to, the use of medical devices, post-surgical complications, transmission between patients and healthcare personnel, and the outcome of frequent antibiotic treatment. On the other hand, we must also consider different host conditions that predispose to HAI acquisition, among them, immunosuppression, either by pre-existing or drug-induced comorbidities³.
Among the drugs administered to the seriously ill patient, different combinations of pain killers and hypnotics are essential to ensure their comfort, care and safety 4 . However, inappropriate use of these drugs may increase morbidity and mortality, mechanical ventilation time, and length of hospital stay.
Sedoanalgesia alters immune function, but its real clinical importance is unknown. Several animal and human studies have demonstrated the immunosuppressive effects of opioids, 5 consequently associating the administration of opioids with increased susceptibility to certain bacterial and viral infections 6 . Morphine is associated with decreased lymphoproliferative processes, Natural killer (NK) lymphocyte activity and the production of interferon-γ and IL-2
7
. Several animal studies suggest that the withdrawal of opioids induces a state of immunosuppression that would increase the risk of infection 8 and therefore, the modification of immunomodulation by certain drugs may be responsible for part of the HAI complications in critical medicine. In this sense, the study by Nseir et al. 9 shows that the discontinuation of the remifentanil opioid in perfusion in critical post-surgical patients represents an independent risk factor for the development of HAI.
The objective of this study is to describe the clinical, demographic and epidemiological characteristics of critical post-surgical patients diagnosed with healthcare-associated infection with admission to the Post-Surgical Resuscitation Unit (URP) for two years, whose sedation was based on association of a hypnotic with remifentanil as a pain killer in continuous perfusion for at least 96 hours, based on the hypothesis, with increase of HAI on withdrawal of the opioid remifentanil.
MATERIAL AND METHODS
Following the approval of the Hospital Ethics Committee, a prospective and observational study of a historical court was conducted in a Post-Surgical Resuscitation Unit with 6 beds during the years 2010-2012.
All patients aged over 18 years with admission to the unit over 4 days were consecutively selected. The study population was the one affected by surgical pathology from any source in which sedation was based on any hypnotic and as pain killer, the opioid remifentanil for at least 96 hours in continuous infusion. Patients who died during admission to the unit and patients with combined analgesia (peripheral or neuroaxial block) were excluded.
Doses of midazolam, propofol, and remifentanil are described in the unit sedoanalgesia protocol, following the Guidelines of the Society of Critical Care Medicine The main variable of our study was the number of infections associated with healthcare acquired in the URP during the days of hospitalization. We also considered incidence density, defined as the number of infections acquired in the unit per 1000 days of hospitalization.
The cut-off point between early and late HAI was established as 6 days before and after remifentanil cessation.
There is a HAI surveillance system with systematic and routine detection of multiresistant germs. Only the infections confirmed by the Microbiology Service were considered for this study. The different HAI were defined according to the definitions of the Centres for Disease Control and Prevention (CDC) 11 . Other variables collected were: age, gender, APACHE II rating (Acute Physiology and Chronic Health Evaluation II), ASA index (American Society of Anaesthesiologists), McCabe score, number and type of comorbidity, cause of hospitalization, number of surgical reinterventions, previous treatment with antibiotics, stay in the Ramsay URP, ratio of use of central and arterial venous catheters, closed system urinary catheters and mechanical ventilation, number of reintubations, tracheostomy, duration and type of antimicrobial agent, dose of remifentan-il, midazolam and propofol, use of neuromuscular blocking drugs and mortality.
For the empirical treatment of infectious processes the recommendations were used based on the therapeutic guidelines of the Sociedade Espanhola de Anestesiologia y Reanimación (Spanish Society of Anaesthesiology and Reanimation) adjusted for the local epidemiology of bacterial resistance of our critical unit
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.
In patients with sepsis on admission, vigorous resuscitation measures with fluid and instauration of hemodynamic support measures by vasopressors were initiated if there was hypotension or lactate> 4 mmol/L, low-dose corticosteroids in patients with septic shock, mechanical invasive ventilation of pulmonary protection, glycaemia control between 150-180 mg/dl, assessment of need for surgical intervention or percutaneous drainage, culture and beginning of empirical antimicrobial treatment based on Surviving Sepsis Campaign guidelines 
RESULTS
The number of patients admitted to the URP during the study period was 1,072. After applying the inclusion and exclusion criteria, the eligible population consisted of 102 patients whose analgesic protocol was carried out by intravenous infusion of remifentanil for at least 96 hours. 56.86% of patients had HAI.
The main demographic data, associated comorbidity conditions, rate of use of medical devices and drugs applied in the sedoanalgesia of the study cohort that developed HAI are presented in Tables 1, 2 The mean infusion rate of remifentanil was 11.4 μg kg-1 h-1. 64% simultaneously received sedation with midazolam, 31% with propofol, and the rest did not receive sedative drugs, only remifentanil. The remifentanil infusion was during the study period of 14.93 ± 11.35 days. The mean medical remifentanil infusion per day of study and in relation to the hypnotic administered is shown in figure 1 . Figure 2 shows the number of HAI in temporal relation to the administration and removal of intravenous remifentanil. We did not observe statistically significant differences in its incidence in relation to discontinuation of remifentanil, using the Mann-Whitney U test (p = 0.19).
The most frequent HAI was pneumonia associated with mechanical ventilation (30.96 per 1000 days of mechanical ventilation), with Pseudomonas aeruginosa being the most frequently isolated germ. The incidence density of primary and/or secondary bacteraemia and urinary tract infection was 23.87 and 9.67 per 1000 days of risk factor, respectively. The germs most involved in multidrug resistance (MDROs) were enterobacteria mainly Klebsiella pneumoniae resistant to extended spectrum betalactamases (ESBL).
The most commonly used antibiotic groups were cephalosporin and aminoglycosides ( figure 3 ). Fungicides were used in 15 cases. 
14
, in postoperative patients, the most frequent HAI are related to ventilator-associated pneumonia (VAP), catheter-related urinary tract infection (UTI) and bacteraemia of unknown origin associated with the catheter. This data is consistent with those of our cohort, since ventilator-associated pneumonia was the most frequent cause, with a DI of 30.96 per 1000 days of mechanical ventilation followed by primary and/or secondary bacteraemia, and urinary tract infection with ID 23.87 and 9.67 per 1,000 days of risk factor, respectively.
The main microbiological causes of the different HAI have not undergone major changes in recent years. In relation to our cohort, Pseudomonas aeruginosa is the most frequently isolated in VAP, E. coli in urinary infections, and Staphylococcus epidermidis in bacteraemia, these results being comparable to those presented in several epidemiological studies on HAI in critical patients
15
. The fact that Pseudomonas aeruginosa is the most frequent pathogen associated with VAP could be justified because this microorganism is related to late VAPs. This circumstance in our study is favoured by the prolonged duration of mechanical ventilation in our patients.
A growing concern in the intensive units is the appearance of multidrug resistant germs, which complicate both the prognosis and the management and evolution of patients, which increases the consumption of resources in the units 16 . In our case, the germs most involved in multidrug resistance (MDROs) were enterobacteria, especially Klebsiella pneumoniae resistant to beta-lactamases (ESBL), which showed, however, a good sensitivity for carbapenems. The low incidence of methicillin-resistant Staphylococcus aureus (MRSA) and the absence of Clostridium difficile carriers are noteworthy. These organisms are identified in national studies as multidrug resistant pathogens
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. The causes of these strains of Vancomycin-Resistant Enterococcus (VRE) may be multifactorial. Among these factors are the progressive increase of elderly patients with higher comorbidity, the current economic crisis leading to increased workloads for healthcare professionals and it is associated with a higher risk of infection by MRSA and ERV
17
, or an incorrect antibiotic policy.
In our cohort, antibiotic therapy was adjusted according to SEDAR recommendations, adjusted to our local ecology. The use of antimicrobials in an early In our study we observed that the factors that may have contributed to the emergence of infections by multidrug resistant microorganisms are the advanced age of our cohort as well as the high comorbidity. In our area there is a bacterial resistance surveillance system, but it is probably necessary to introduce and/or potentiate other strategies, such as the molecular typing of isolates, intensification of hygiene measures control, regrouping or cohorting of patients, rotation and restriction in the use of antibiotics, and a rigorous follow-up of patients infected and/or colonized by resistant germs
19
. Another element to be considered in our study as a factor favouring HAI is the use of prolonged sedoanalgesia based on the use of remifentanil, associated or not with propofol or midazolam hypnotics, to achieve an optimal level of sedation. The transcendence of prolonged use in sedation of critically ill patients may be relevant but there are no clinical studies demonstrating that the specific use of any analgesic or hypnotic drug has an impact on patient survival. Several animal studies suggest that withdrawal of opioids after a variable time of administration induces a state of immunosuppression that would increase the risk of infection 8, 20 . In this sense, the effect of certain drugs on immunomodulation could increase the risk of acquiring infections associated with healthcare in intensive units. Sedation in our work was performed using the midazolam or propofol hypnotics according to the protocol attached. In patients with greater severity, sedoanalgesia was based on the midazolam-remifentanil binomial. Although some studies 21 have suggested the importance of choosing this in immunocompromised patients with a high risk of infection, we have not found that the applied hypnotic correlates with an increase in HAI when adjusted for severity, medical device utilization ratio and hospital stay.
On the other hand, our study shows that the acute use and the interruption of opioid remifentanil is an independent risk factor for nosocomial infection, unlike the results presented by the Nseir et al. 9 group. This study showed, after a logistic regression analysis, that there is a high incidence of nosocomial infections during the 4 days after the cessation of analgesia based on opioid remifentanil. In our study, it was observed that patients belonging to the HAI group require more days of sedoanalgesia with remifentanil, with longer exposure to extrinsic factors of infection, such as mechanical ventilation, central venous catheters and urinary catheter exposing them to a higher HAI risk. These data could explain the differences of our results with those obtained in the work of Nseir et al.
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. Our findings are consistent with the study by Cronin et al.
22
, which shows that infusion of fentanyl has no effect on cellular immune function in healthy volunteers.
For preventing these infections, the implementation of strategies to prevent the different HAI is necessary, since it is possible to prevent most of them and therefore, to put all the resources at our disposal to avoid them. Thus, it is possible to implement both measures common to different HAI and specific ones, depending on the area that presents the greatest needs (training, reduction of risk factors, and adherence to clinical guidelines for the prevention of infection)
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. The study has a number of limitations. First, the sample size is limited and extracted from a single intensive unit. Second, the bias of hypnotic choice depending on the hemodynamic instability of the postoperative patients, as it influences their prior immunological status, among others.
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In conclusion, HAI are the most frequent complication of hospitalized patients. VAP is the most prevalent nosocomial infection and Pseudomonas aeruginosa is the most frequently isolated germ. The germs most involved in multidrug resistance (MDROs) are mainly enterobacteria, mainly Klebsiella pneumoniae resistant to extended spectrum beta-lactamases (ESBL). It is necessary to implement prevention strategies for the different HAI, since most of them can be avoided. The statement that remifentanil discontinuation is associated with a high incidence of HAI was not verified in our study.
Given the importance of the topic and areas of uncertainty, it could be of interest to carry out multicentre, controlled, and larger series studies to elucidate all factors related to HAI in critically ill 
